https://www.benzinga.com/news/earnings/23/03/31278269/neuroneticss-return-on-capital-employed-overview
Neuronetics's Return On Capital Employed Overview - Neuronetics (NASDAQ:STIM) - Benzinga
return on capital employedneuroneticsoverviewnasdaqstim
https://menafn.com/1109655937/Neuronetics-Announces-Clinical-Presence-At-The-2025-Clinical-TMS-Society-Annual-Meeting-And-Progress-In-Greenbrooks-Personalized-Care-Trial-Program
Neuronetics Announces Clinical Presence At The 2025 Clinical TMS Society Annual Meeting And...
Neuronetics Announces Clinical Presence At The 2025 Clinical TMS Society Annual Meeting And Progress In Greenbrook's Personalized Care Trial Program....
at the
https://simplywall.st/stocks/us/healthcare/nasdaq-stim/neuronetics/news/insider-sellers-might-regret-selling-neuronetics-shares-at-a
Insider Sellers Might Regret Selling Neuronetics Shares at a Lower Price Than Current Market Value...
Neuronetics, Inc.'s (NASDAQ:STIM) value has fallen 12% in the last week, but insiders who sold US$1.6m worth of stock...
https://www.biospace.com/press-releases/neuronetics-reports-inducement-grant-under-nasdaq-listing-rule-5635c4-june-19-2025
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - June 19, 2025 - BioSpace
https://robinhood.com/us/en/stocks/STIM/
Neuronetics: STIM Stock Price Quote & News | Robinhood
View the real-time STIM price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees, Gold...
stock price quoteneuroneticsstimnewsrobinhood
https://www.home.saxo/en-sg/markets/stocks/stim-xnas
Neuronetics Inc. stock | Saxo
Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for...
neuroneticsincstocksaxo
https://www.biospace.com/neuronetics-to-report-third-quarter-2023-financial-and-operating-results-and-host-conference-call
Neuronetics to Report Third Quarter 2023 Financial and Operating Results and Host Conference Call -...
Aug 7, 2024 - Neuronetics, Inc. today announced that it plans to release third quarter 2023 financial and operating results prior to market open on Tuesday, November 7th,...
https://theorg.com/org/neuronetics?person=keith-j-sullivan
Neuronetics | The Org
Neuronetics, Inc., is the market leader in Transcranial Magnetic Stimulation technology for the treatment of Major Depressive Disorder.
neuronetics
https://www.marketscreener.com/quote/stock/NEURONETICS-INC-44403632/news-key-events/
Neuronetics, Inc.: Latest Headlines - Nasdaq Stock Exchange - MarketScreener
Find the latest highlights on Neuronetics, Inc. at the Nasdaq stock exchange.
nasdaq stock exchangelatest headlinesneuroneticsincmarketscreener
https://www.biospace.com/neuronetics-reports-first-quarter-2020-financial-and-operating-results
Neuronetics Reports First Quarter 2020 Financial and Operating Results - BioSpace
May 5, 2020 - Neuronetics, Inc., a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for...
first quarteroperating resultsneuroneticsreports2020
https://www.finanznachrichten.de/chart-tool/aktie/neuronetics-inc.htm
NEURONETICS Chartanalyse
Chart zur NEURONETICS INC Aktie. Alle Charts zu Ihren Aktien.
neuroneticschartanalyse
https://theorg.com/org/neuronetics/teams/human-resources
Neuronetics - Human Resources | The Org
The Human Resources team at Neuronetics is responsible for managing all employee-related functions, including talent acquisition, employee relations,...
human resourcesneuronetics
https://www.home.saxo/en-mena/markets/stocks/stim-xnas
Neuronetics Inc. stock | Saxo Bank
Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for...
neuroneticsincstocksaxobank
https://theorg.com/org/neuronetics/org-chart/cory-anderson
Cory Anderson - Chief Technology Officer at Neuronetics | The Org
chief technology officercory andersonneuronetics
https://www.marketscreener.com/quote/stock/NEURONETICS-INC-44403632/news/Earnings-Flash-STIM-NEURONETICS-Reports-Q3-Revenue-18-5M-48334928/
Earnings Flash (STIM) NEURONETICS Reports Q3 Revenue $18.5M | MarketScreener
earnings flashstimneuroneticsreportsq3
https://www.finanznachrichten.de/aktien-analysen/neuronetics-inc.htm
NEURONETICS-AKTIE kaufen? Analysen, Kursziele & Empfehlungen zu A2JPMY
NEURONETICS-Aktie jetzt kaufen? Analysen und Kursziele:
aktie kaufenneuroneticsanalysenkurszieleempfehlungen
https://finviz.com/quote?a=30565236&t=STIM
STIM - Neuronetics Inc Stock Price and Quote
STIM - Neuronetics Inc - Stock screener for investors and traders, financial visualizations.
stock pricestimneuroneticsincquote
https://www.marketscreener.com/news/neuronetics-insider-bought-shares-worth-1-418-490-according-to-a-recent-sec-filing-ce7e5edfdd80fe21
Neuronetics Insider Bought Shares Worth $1,418,490, According to a Recent SEC Filing |...
Mar 20, 2026 - Jorey Chernett, 10% Owner, on March 18, 2026, executed a purchase for 1,057,400 shares in Neuronetics for $1,418,490. Following the Form 4 filing with the SEC,...
according to a recent
https://www.marketscreener.com/quote/stock/NEURONETICS-INC-44403632/news-broker-research/
Neuronetics, Inc.: Analyst Recommendations and Opinions | STIM | US64131A1051 | MarketScreener
Neuronetics, Inc.: Financial analyst guidance for Neuronetics, Inc. Stock | Nasdaq: STIM | Nasdaq
recommendations and opinionsneuroneticsincanalyststim
https://www.prnewswire.com/news-releases/neuronetics-announces-the-appointment-of-keith-j-sullivan-as-president-and-chief-executive-officer-301093411.html
Neuronetics Announces the Appointment of Keith J. Sullivan as President and Chief Executive Officer
/PRNewswire/ -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on improving the lives of patients who suffer from...
https://www.biospace.com/neuronetics-to-present-at-the-canaccord-genuity-virtual-medtech-and-diagnostics-forum
Neuronetics to Present at the Canaccord Genuity Virtual MedTech & Diagnostics Forum - BioSpace
Nov 13, 2020 - Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the...
at thecanaccord genuity
https://www.fiercebiotech.com/medical-devices/ge-backs-depression-neurostim-startup-neuronetics-34m-series-f-round
GE backs depression neurostim startup Neuronetics in $34M Series F round | Fierce Biotech
Apr 27, 2015 - Neuronetics has closed a $34.3 million Series F round to further commercialize its NeuroStar transcranial magnetic stimulation therapy system to treat...
https://www.biospace.com/neuronetics-ceo-chris-thatcher-to-ring-nasdaq-closing-bell-on-october-22-in-honor-of-national-depression-awareness-month
Neuronetics CEO Chris Thatcher to Ring Nasdaq Closing Bell on October 22 in Honor of National...
Oct 21, 2019 - Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the...
https://simplywall.st/stocks/us/healthcare/nasdaq-stim/neuronetics/news/neuronetics-nasdaqstim-growing-losses-dont-faze-investors-as
Neuronetics' (NASDAQ:STIM) growing losses don't faze investors as the stock hikes 13% this past...
When you buy shares in a company, there is always a risk that the price drops to zero. But when you pick a company that...